Association between body weight and tocilizumab effectiveness in rheumatoid arthritis: results from the BSRBR-RA
Body weight was associated with the initial response to SC tocilizumab, although the difference in response was small, but not drug persistence. Physicians should monitor the body weight of patients and consider interventions to promote maintenance of a healthy weight.
Authors
- Kimme Leanne Hyrich (ORCID: https://orcid.org/0000-0001-8242-9262)
- Lianne Kearsley‐Fleet (ORCID: https://orcid.org/0000-0003-0377-1575)
- Man Fung Tsoi (ORCID: https://orcid.org/0000-0002-9892-0125)
- James Bluett (ORCID: https://orcid.org/0000-0001-5062-5779)
- Narges Azadbakht
- Kath Watson
Institutions
- Manchester Academic Health Science Centre (GB)
- University of Manchester (GB)
- Manchester University NHS Foundation Trust (GB)
- Arthritis UK (GB)
- NIHR Manchester Biomedical Research Centre (GB)
Publication Details
- Journal
- Lara D. Veeken
- Published
- 2024-09-13
- DOI
- https://doi.org/10.1093/rheumatology/keae500
- Citations
- 3
- Primary Topic
- Rheumatoid Arthritis Research and Therapies
- Type
- article
- Field-Weighted Citation Impact
- 1.41
Funders
- National Institute for Health and Care Research
- Department of Health and Social Care
- British Society for Rheumatology
- Versus Arthritis
- Manchester Biomedical Research Centre